Product Information
AUVI-Q 0.1 MG AUTO-INJECTOR is a brand product labeled by kaleo, Inc, priced at $297.6436 per EA under NDC 60842002102. Its NADAC has been published 94 times since Sep 11, 2024.
Strength
.1 mg/.1mL
Manufacturer
kaleo, IncNDC
60842002102
Classification
Brand
Dosage Form
INJECTION, SOLUTION
Route
INTRAMUSCULAR
Last Updated
6/17/2026
Active Ingredients
EPINEPHRINEApproval Type
New Drug (NDA)
FDA Application
NDA201739On Market Since
11/17/2017
Pharmacological Classes
Price Statistics
The NADAC for AUVI-Q 0.1 MG AUTO-INJECTOR has been published 94 times since Sep 11, 2024, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $297.6436 per EA |
|---|---|
| All-time high | $298.5681 (Oct 16, 2024) |
| All-time low | $297.5607 (Apr 22, 2026) |
| 52-week high | $297.8367 |
| 52-week low | $297.5607 |
| Median price | $297.8058 |
| Average price | $297.9113 |
| Largest weekly change | -0.1% (Jan 22, 2025) |
| Weeks tracked | 94 |
| Tracking since | Sep 11, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the epinephrine market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of AUVI-Q 0.1 MG AUTO-INJECTOR?
The current National Average Drug Acquisition Cost (NADAC) for AUVI-Q 0.1 MG AUTO-INJECTOR, manufactured by kaleo, Inc, is $297.6436 per EA (NDC 60842002102), effective Jun 24, 2026.
How has the price of AUVI-Q 0.1 MG AUTO-INJECTOR changed over time?
Over the history we have for it, the NADAC for AUVI-Q 0.1 MG AUTO-INJECTOR has held within roughly two percent of its current level. It has been tracked across 94 weekly CMS publications since Sep 11, 2024.
What are the highest and lowest recorded NADAC prices for AUVI-Q 0.1 MG AUTO-INJECTOR?
Since Sep 11, 2024, the NADAC for AUVI-Q 0.1 MG AUTO-INJECTOR has ranged from a low of $297.5607 (Apr 22, 2026) to a high of $298.5681 (Oct 16, 2024), with a median of $297.8058 per EA.
Are there cheaper alternatives to AUVI-Q 0.1 MG AUTO-INJECTOR?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of AUVI-Q 0.1 MG AUTO-INJECTOR, so no direct lower-cost alternative is listed.
Who manufactures AUVI-Q 0.1 MG AUTO-INJECTOR?
AUVI-Q 0.1 MG AUTO-INJECTOR (NDC 60842002102) is labeled by kaleo, Inc, and CMS classifies it as a brand product.
Related Drugs
Same classification